MACQUARIE GROUP LTD - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$161,000
-25.5%
61,2550.0%0.00%
Q2 2023$216,000
+14.3%
61,2550.0%0.00%
Q1 2023$189,000
-27.0%
61,2550.0%0.00%
Q4 2022$259,000
+78.6%
61,2550.0%0.00%
Q3 2022$145,000
-17.1%
61,2550.0%0.00%
Q2 2022$175,000
-0.6%
61,2550.0%0.00%
Q1 2022$176,000
-5.4%
61,2550.0%0.00%
Q4 2021$186,000
-61.1%
61,255
-10.2%
0.00%
Q3 2021$478,000
-15.8%
68,248
+10.3%
0.00%
Q2 2021$568,000
-5.5%
61,8940.0%0.00%
-100.0%
Q1 2021$601,000
-5.8%
61,894
-0.5%
0.00%0.0%
Q4 2020$638,000
+1.6%
62,1970.0%0.00%0.0%
Q3 2020$628,000
-3.2%
62,1970.0%0.00%0.0%
Q2 2020$649,000
+25.5%
62,197
+1.5%
0.00%0.0%
Q1 2020$517,000
-3.5%
61,2550.0%0.00%0.0%
Q4 2019$536,000
-95.6%
61,255
-94.5%
0.00%
-95.0%
Q3 2019$12,099,000
-69.9%
1,123,877
-64.4%
0.02%
-13.0%
Q2 2019$40,167,000
+4.9%
3,160,206
+220.1%
0.02%
-64.6%
Q1 2019$38,292,000
+128.0%
987,168
+19.6%
0.06%
+103.1%
Q4 2018$16,793,000
-43.5%
825,196
+27.3%
0.03%
-33.3%
Q3 2018$29,732,000
+6.3%
648,463
+37.2%
0.05%0.0%
Q2 2018$27,964,000
+93113.3%
472,764
+157488.0%
0.05%
Q4 2017$30,0000.0%300
-25.0%
0.00%
Q3 2015$30,000
-36.2%
4000.0%0.00%
Q2 2015$47,000
-97.8%
400
-95.5%
0.00%
-100.0%
Q1 2015$2,105,000
+174.4%
8,914
+120.1%
0.00%
+100.0%
Q4 2014$767,0004,0500.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$12,636,0002.61%
AIGH Capital Management LLC 964,590$9,376,0001.97%
Worth Venture Partners, LLC 226,758$2,204,0001.07%
Camber Capital Management LP 2,555,000$24,835,0000.85%
Palo Alto Investors LP 1,392,997$13,540,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,769,795$36,642,0000.77%
GLOBEFLEX CAPITAL L P 428,680$4,167,0000.76%
Zebra Capital Management LLC 34,243$333,0000.37%
Sofinnova Investments, Inc. 344,917$3,353,0000.20%
RICE HALL JAMES & ASSOCIATES, LLC 605,792$5,888,0000.19%
View complete list of PUMA BIOTECHNOLOGY INC shareholders